Selection and testing of the suitability of antigens for the diagnosis of neurodegeneration (Q10677): Difference between revisions
Jump to navigation
Jump to search
(Created claim: summary (P836): The project will provide for the selection and characterisation of antigens for the diagnosis of neurodegenerative diseases and, on the other hand, their commercial availability, possibly their own preparation, the status of intellectual property rights and their intended use for differential diagnosis of the intended diseases. The selected antigens will be further verified on real sample panels with known diagnosis., Adding English summary) |
(Changed an Item) |
||
| Property / programme | |||
| Property / programme: Enterprise and Innovation for Competitiveness - CZ - ERDF / rank | |||
Normal rank | |||
Revision as of 17:35, 25 March 2020
Project in Czech Republic financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Selection and testing of the suitability of antigens for the diagnosis of neurodegeneration |
Project in Czech Republic financed by DG Regio |
Statements
189,000.0 Czech koruna
0 references
252,000.0 Czech koruna
0 references
75 percent
0 references
8 March 2017
0 references
31 December 2017
0 references
31 December 2017
0 references
VIDIA spol. s r.o.
0 references
49°59'0.49"N, 14°30'9.11"E
0 references
25250
0 references
V rámci projektu bude proveden výběr a charakterizace antigenů pro diagnostiku neurodegenerativních onemocnění, jednak s ohledem na jejich komerční dostupnost, popř. možnou vlastní přípravu, na stav práv duševního vlastnictví a jednak s ohledem na jejich předpokládané využití pro diferenciální diagnostiku zamýšlených onemocnění. Vybrané antigeny budou dále ověřeny na panelech reálných vzorků se známou diagnózou. a. (Czech)
0 references
The project will provide for the selection and characterisation of antigens for the diagnosis of neurodegenerative diseases and, on the other hand, their commercial availability, possibly their own preparation, the status of intellectual property rights and their intended use for differential diagnosis of the intended diseases. The selected antigens will be further verified on real sample panels with known diagnosis. (English)
0 references
Identifiers
CZ.01.1.02/0.0/0.0/16_045/0009746
0 references